U-Chart Analysis:KISSEI PHARMACEUTICAL CO.,LTD.:4547

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KISSEI PHARMACEUTICAL CO.,LTD. Go to web site 4547 Medicals 東証プライム March 1, 2000 1988.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 22,894 25,893 30,013 20,456 36,329
Other Current AssetsHelp 81,657 74,748 69,329 72,509 60,348
Tangible Fixed AssetsHelp 24,861 24,579 24,074 24,290 24,605
Intangible Fixed AssetHelp 1,683 1,507 1,569 1,640 1,511
Investments and OthersHelp 129,834 94,473 112,793 149,966 109,001
Total AssetsHelp 260,929 221,200 238,087 268,861 231,794
Total Current LiabilitiesHelp 40,664 26,983 36,474 49,546 39,315
Total Long-term LiabilitiesHelp 236 317 227 0 13
Shareholder's EquityHelp 220,029 193,900 201,386 219,315 192,466
Total LiabilitiesHelp 260,929 221,200 238,087 268,861 231,794

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 75,579 67,493 65,381 69,044 63,234
Total Sales 75,579 67,493 65,381 69,044 63,234
Cost of SalesHelp 38,238 35,118 34,143 36,321 28,340
Other Costs and RevenueHelp 26,179 21,846 18,316 27,438 32,076
Total CostsHelp 64,417 56,964 52,459 63,759 60,416
Net RevenueHelp 37,341 32,375 31,238 32,723 34,894
Earnings Before TaxHelp 14,449 13,680 16,507 7,476 4,630
Net IncomeHelp 11,162 10,529 12,922 5,285 2,818
Net Income 11,162 10,529 12,922 5,285 2,818

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -1,678 -6,680 1,533 -2,543 13,933
Investing Cash Flow(ICF)Help 8,690 6,001 10,776 -9,329 490
Financing Cash FlowHelp -10,006 -3,420 -2,756 -4,000 -4,419
Exchange Difference of Cash and Cash EquivalentsHelp -3 -21 4 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -2,997 -4,120 9,557 -15,872 10,004

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KISSEI PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

MediciNova,Inc
HISAMITSU PHARMACEUTICAL CO.,INC.
CanBas Co.,Ltd.
DENKA SEIKEN Co.,Ltd.
SSP CO.,LTD.
ROHTO PHARMACEUTICAL CO.,LTD.
FunPep Company Limited
Kidswell Bio Corporation
R-TECH UENO,LTD.
Noile-Immune Biotech Inc.